The journal "Oncology" was founded in 1981, and Professor Gu Suiyue, a leading figure in tumor pathology in my country, served as the first editor-in-chief. Since then, Professor Yu Xinsheng, a famous Chinese expert in immunology and cell biology, and Professor Gao Yutang, an internationally renowned expert in tumor epidemiology, have successively served as editors-in-chief of the journal. Since December 2021, Professor Liu Yingbin, an expert in biliary and pancreatic surgery, has served as editor-in-chief of the journal. "Oncology" is supervised by the Ministry of Education of China and sponsored by Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and Shanghai Institute of Oncology. It has long been ranked among the core journals of Chinese scientific and technological papers (statistical source) and has been included in many important international databases, including Embase, Scopus, DOAJ, CA, JST, CSA, VINITI, Index Copemicus, WPRIM, etc. It is an important platform for domestic academic exchanges in oncology and has made contributions to academic exchanges in oncology.